Pain Device Firm’s Undoing Over $16K ‘Piece of Plastic’
Executive Summary
Neuromodulation company Stimwave has agreed to pay $10M in fines and the ex-CEO is facing health care fraud charges after a whistleblower revealed the company was selling a fraudulent “receiver” component.